Literature DB >> 1997094

Mutations in p53 do not account for heritable breast cancer: a study in five affected families.

J Prosser1, P A Elder, A Condie, I MacFadyen, C M Steel, H J Evans.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1997094      PMCID： PMC1971779          DOI： 10.1038/bjc.1991.44

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  31 in total

1.  Participation of p53 cellular tumour antigen in transformation of normal embryonic cells.

Authors:  D Eliyahu; A Raz; P Gruss; D Givol; M Oren
Journal:  Nature       Date:  1984 Dec 13-19       Impact factor: 49.962

2.  Evidence that p53 behaves as a tumour suppressor gene in sporadic breast tumours.

Authors:  J Prosser; A M Thompson; G Cranston; H J Evans
Journal:  Oncogene       Date:  1990-10       Impact factor: 9.867

3.  Suppression of malignancy in human cells.

Authors:  E J Stanbridge
Journal:  Nature       Date:  1976-03-04       Impact factor: 49.962

4.  Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells.

Authors:  D I Linzer; A J Levine
Journal:  Cell       Date:  1979-05       Impact factor: 41.582

5.  Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouse.

Authors:  A B DeLeo; G Jay; E Appella; G C Dubois; L W Law; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1979-05       Impact factor: 11.205

6.  p53, a transformation-related cellular-encoded protein, can be used as a biochemical marker for the detection of primary mouse tumor cells.

Authors:  V Rotter
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

7.  Characterization of human p53 antigens employing primate specific monoclonal antibodies.

Authors:  R Thomas; L Kaplan; N Reich; D P Lane; A J Levine
Journal:  Virology       Date:  1983-12       Impact factor: 3.616

8.  Detection of a common feature in several human tumor cell lines--a 53,000-dalton protein.

Authors:  L V Crawford; D C Pim; E G Gurney; P Goodfellow; J Taylor-Papadimitriou
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

9.  Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation.

Authors:  L F Parada; H Land; R A Weinberg; D Wolf; V Rotter
Journal:  Nature       Date:  1984 Dec 13-19       Impact factor: 49.962

10.  Radioimmunoassay of the cellular protein p53 in mouse and human cell lines.

Authors:  S Benchimol; D Pim; L Crawford
Journal:  EMBO J       Date:  1982       Impact factor: 11.598
View more
  21 in total

Review 1.  Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility.

Authors:  M M de Jong; I M Nolte; G J te Meerman; W T A van der Graaf; J C Oosterwijk; J H Kleibeuker; M Schaapveld; E G E de Vries
Journal:  J Med Genet       Date:  2002-04       Impact factor: 6.318

2.  Population-based estimate of the contribution of TP53 mutations to subgroups of early-onset breast cancer: Australian Breast Cancer Family Study.

Authors:  Judy Mouchawar; Christopher Korch; Tim Byers; Todd M Pitts; Efang Li; Margaret R E McCredie; Graham G Giles; John L Hopper; Melissa C Southey
Journal:  Cancer Res       Date:  2010-05-25       Impact factor: 12.701

3.  Prevalence of TP53 germ line mutations in young Pakistani breast cancer patients.

Authors:  Muhammad U Rashid; Sidra Gull; Kashif Asghar; Noor Muhammad; Asim Amin; Ute Hamann
Journal:  Fam Cancer       Date:  2012-06       Impact factor: 2.375

4.  Absence of p53 germ-line mutations in bilateral breast cancer patients.

Authors:  R Lidereau; T Soussi
Journal:  Hum Genet       Date:  1992-05       Impact factor: 4.132

Review 5.  Molecular genetics of familial breast-ovarian cancer.

Authors:  E J van Rensburg; B A Ponder
Journal:  J Clin Pathol       Date:  1995-09       Impact factor: 3.411

Review 6.  Familial breast cancer and genes involved in breast carcinogenesis.

Authors:  A Lindblom
Journal:  Breast Cancer Res Treat       Date:  1995-05       Impact factor: 4.872

7.  Four separate regions on chromosome 17 show loss of heterozygosity in familial breast carcinomas.

Authors:  A Lindblom; L Skoog; T I Andersen; S Rotstein; M Nordenskjöld; C Larsson
Journal:  Hum Genet       Date:  1993-03       Impact factor: 4.132

8.  William L. McGuire Memorial Symposium. The role and prognostic significance of p53 gene alterations in breast cancer.

Authors:  R M Elledge; S A Fuqua; G M Clark; P Pujol; D C Allred
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

Review 9.  Late onset Li-Fraumeni Syndrome with bilateral breast cancer and other malignancies: case report and review of the literature.

Authors:  Karin Kast; Mechthild Krause; Markus Schuler; Katrin Friedrich; Barbara Thamm; Andrea Bier; Wolfgang Distler; Stefan Krüger
Journal:  BMC Cancer       Date:  2012-06-06       Impact factor: 4.430

10.  Zinc finger point mutations within the WT1 gene in Wilms tumor patients.

Authors:  M H Little; J Prosser; A Condie; P J Smith; V Van Heyningen; N D Hastie
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.